TLA

L(+)-TARTARIC ACID

Find entries where: TLA

is present as a standalone ligand in 586 entries

as a non-polymer is covalently linked to polymer or other heterogen groups 8 entries

Find related ligands:

Similar Ligands (Stereospecific)

Similar Ligands (including Stereoisomers)

Similar Ligands (Quick Screen)

Similar Ligands (Substructure Stereospecific)

Similar Ligands (Substructure including Stereoisomers)

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	L(+)-TARTARIC ACID
Identifiers	(2R,3R)-2,3-dihydroxybutanedioic acid
Formula	C₄ H₆ O₆
Molecular Weight	150.087
Type	NON-POLYMER
Isomeric SMILES	[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
InChI	InChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m1/s1
InChIKey	FEWJPZIEWOKRBE-JCYAYHJZSA-N

Chemical Details
Formal Charge	0
Atom Count	16
Chiral Atom Count	2
Bond Count	15
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB09459
Name	L-tartaric acid
Groups	experimental
Description	Tartaric acid is a white crystalline organic acid that occurs naturally in many plants, most notably in grapes.Tartaric is an alpha-hydroxy-carboxylic acid, is diprotic and aldaric in acid characteristics, and is a dihydroxyl derivative of succinic acid.
Synonyms	(+)-Weinsäure Weinsteinsäure Tartaric acid (R,R)-Tartaric acid ácido tartárico L-tartaric acid (R,R)-(+)-tartaric acid (+)-(R,R)-tartaric acid (2R,3R)-2,3-dihydroxysuccinic acid (2R,3R)-Tartaric acid Rechtsweinsäure (+)-Tartaric acid (+)-L-tartaric acid (2R,3R)-2,3-Dihydroxybernsteinsäure L-threaric acid
Brand Names	Bicaruvas Unik Zoru Tab Gingera Effervescent Antacid Unik Zoru Pwr E-Z-gas 2 Granules Brioschi Childrens Effervescent Antacid Urasal Granules Brioschi Effervescent Antacid Baros Effervescent Granules
Indication	Tartaric Acid is primarily indicated in conditions like Antiscorbutic, Antiseptic.
Categories	Acids, Acyclic Carbohydrates Chelating Agents Dicarboxylic Acids Hydroxy Acids Sugar Acids Urinary Alkalinisers
CAS number	87-69-4

Related Resource References

Resource Name	Reference
PubChem	444305
ChEMBL	CHEMBL1236315
ChEBI	CHEBI:15671
CCDC/CSD	FINTAZ02, KIMBEQ, FINTAZ03, KILNAX, IQOMIM01, IQOMIM02, IQOMIM07, IQOMIM05, IQOMIM04, IQOMIM06, IQOMIM22, ANOLIZ, IQOMIM03, IQOMIM08, IQOMIM09, DIZSUD, IRACAH, KAYZIT, HUTRIA, ANOLUL, ACETEJ, IQOMIM, IQOMIM12, IXOVUN, IQOMIM14, IQOMIM19, IQOMIM20, IQOMIM18, IQOMIM17, IQOMIM15, IQOMIM13, ACESAE, IQOMIM16, IQOMIM11, IZAHID
COD	1520169, 7200948, 2011939, 7225610, 7225609, 7225611, 7225612, 7225613, 7225614, 7225615, 7225616, 7225617, 7225628, 7225629, 7225630, 7225631, 7225633, 7225632, 7225634, 7225635, 7225636, 7225638, 7225637, 7205663, 7205665, 2021499, 2021501, 2021500, 2021502, 2021503, 2021504, 2021505, 2311127, 2021506, 2021507, 2021508, 2200365

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.